Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Longer time from previous perioperative chemotherapy (TFPC) ≥ 78 weeks and Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0 were independently prognostic for better survival with cisplatin-based first-line chemotherapy for advanced urothelial carcinoma (UC) after previous periop...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Genitourin Cancer
Hlavní autoři: Necchi, Andrea, Pond, Gregory R., Giannatempo, Patrizia, Di Lorenzo, Giuseppe, Eigl, Bernhard J., Locke, Jenn, Pal, Sumanta K., Agarwal, Neeraj, Poole, Austin, Vaishampayan, Ulka N., Niegisch, Guenter, Hussain, Syed A., Singh, Parminder, Bellmunt, Joaquim, Sonpavde, Guru
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477939/
https://ncbi.nlm.nih.gov/pubmed/25450035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2014.08.010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky